Establishment of a cynomolgus macaque model of influenza B virus infection

Virology

Volumn 407, Issue 2, 2010, Pages 178-184

  Kitano, Mitsutaka ^a,b   Itoh, Yasushi ^a   Kodama, Makoto ^b   Ishigaki, Hirohito ^a   Nakayama, Misako ^a   Nagata, Tomoya ^a   Ishida, Hideaki ^a   Tsuchiya, Hideaki ^a   Torii, Ryuzo ^a   Baba, Keiko ^b   Yoshida, Ryu ^b   Sato, Akihiko ^b   Ogasawara, Kazumasa ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Cytokine; Influenza B virus; Non human primate

Indexed keywords

INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEVER; IMMUNE RESPONSE; INFLUENZA B; MACACA; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VIRUS DETECTION; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; BLOOD; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS B; ISOLATION AND PURIFICATION; MACACA FASCICULARIS; METABOLISM; PATHOGENICITY; PATHOPHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MACACA FASCICULARIS; VIRUS REPLICATION;

ANIMALIA; INFLUENZA B VIRUS; MACACA; PRIMATES;

EID: 77957656903     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.08.006     Document Type: Article

References (31)

1. Baas T., Baskin C.R., Diamond D.L., Garcia-Sastre A., Bielefeldt-Ohmann H., Tumpey T.M., Thomas M.J., Carter V.S., Teal T.H., Van Hoeven N., Proll S., Jacobs J.M., Caldwell Z.R., Gritsenko M.A., Hukkanen R.R., Camp D.G., Smith R.D., Katze M.G. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 2006, 80(21):10813-10828.
2. Baskin C.R., Bielefeldt-Ohmann H., Garcia-Sastre A., Tumpey T.M., Van Hoeven N., Carter V.S., Thomas M.J., Proll S., Solorzano A., Billharz R., Fornek J.L., Thomas S., Chen C.H., Clark E.A., Murali-Krishna K., Katze M.G. Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J. Virol. 2007, 81(21):11817-11827.
3. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., Tolnay A.E., Albrecht R., Pyles J.A., Olson P.H., Aicher L.D., Rosenzweig E.R., Murali-Krishna K., Clark E.A., Kotur M.S., Fornek J.L., Proll S., Palermo R.E., Sabourin C.L., Katze M.G. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl Acad. Sci. USA 2009, 106(9):3455-3460.
4. Carroll T.D., Matzinger S.R., Genesca M., Fritts L., Colon R., McChesney M.B., Miller C.J. Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. J. Immunol. 2008, 180(4):2385-2395.
5. Conn C.A., McClellan J.L., Maassab H.F., Smitka C.W., Majde J.A., Kluger M.J. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 1995, 268(1 Pt 2):R78-R84.
6. Francis T. A new type of virus from epidemic influenza. Science 1940, 92(2392):405-408.
7. Fritz R.S., Hayden F.G., Calfee D.P., Cass L.M., Peng A.W., Alvord W.G., Strober W., Straus S.E. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J. Infect. Dis. 1999, 180(3):586-593.
8. Govorkova E.A., Rehg J.E., Krauss S., Yen H.L., Guan Y., Peiris M., Nguyen T.D., Hanh T.H., Puthavathana P., Long H.T., Buranathai C., Lim W., Webster R.G., Hoffmann E. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 2005, 79(4):2191-2198.
9. Hatakeyama S., Sugaya N., Ito M., Yamazaki M., Ichikawa M., Kimura K., Kiso M., Shimizu H., Kawakami C., Koike K., Mitamura K., Kawaoka Y. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 2007, 297(13):1435-1442.
10. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W., Straus S.E. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 1998, 101(3):643-649.
11. Itoh Y., Ozaki H., Tsuchiya H., Okamoto K., Torii R., Sakoda Y., Kawaoka Y., Ogasawara K., Kida H. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 2008, 26(4):562-572.
12. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., Sakabe S., Imai M., Hatta Y., Watanabe S., Li C., Yamada S., Fujii K., Murakami S., Imai H., Kakugawa S., Ito M., Takano R., Iwatsuki-Horimoto K., Shimojima M., Horimoto T., Goto H., Takahashi K., Makino A., Ishigaki H., Nakayama M., Okamatsu M., Takahashi K., Warshauer D., Shult P.A., Saito R., Suzuki H., Furuta Y., Yamashita M., Mitamura K., Nakano K., Nakamura M., Brockman-Schneider R., Mitamura H., Yamazaki M., Sugaya N., Suresh M., Ozawa M., Neumann G., Gern J., Kida H., Ogasawara K., Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460(7258):1021-1025.
13. Itoh Y., Ozaki H., Ishigaki H., Sakoda Y., Nagata T., Soda K., Isoda N., Miyake T., Ishida H., Okamoto K., Nakayama M., Tsuchiya H., Torii R., Kida H., Ogasawara K. Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques. Vaccine 2010, 28(3):780-789.
14. Kawai N., Ikematsu H., Iwaki N., Hirotsu N., Kashiwagi S. Prevalence of influenza B during the 2004-2005 season in Japan. Clin. Infect. Dis. 2006, 43(9):1226-1228.
15. Kawai N., Ikematsu H., Iwaki N., Kawashima T., Maeda T., Mitsuoka S., Kondou K., Satoh I., Miyachi K., Yamaga S., Shigematsu T., Hirotsu N., Kashiwagi S. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J. Infect. 2007, 55(3):267-272.
16. Lee N., Chan P.K., Hui D.S., Rainer T.H., Wong E., Choi K.W., Lui G.C., Wong B.C., Wong R.Y., Lam W.Y., Chu I.M., Lai R.W., Cockram C.S., Sung J.J. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J. Infect. Dis. 2009, 200(4):492-500.
17. Lynch G.W., Selleck P., Sullivan J.S. Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza. J. Mol. Genet. Med. 2009, 3(2):205-209.
18. McCullers J.A., Saito T., Iverson A.R. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J. Virol. 2004, 78(23):12817-12828.
19. McCullers J.A., Hoffmann E., Huber V.C., Nickerson A.D. A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence. Virology 2005, 336(2):318-326.
20. Nerome R., Hiromoto Y., Sugita S., Tanabe N., Ishida M., Matsumoto M., Lindstrom S.E., Takahashi T., Nerome K. Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch. Virol. 1998, 143:1569-1583.
21. Newland J.G., Romero J.R., Varman M., Drake C., Holst A., Safranek T., Subbarao K. Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin. Infect. Dis. 2003, 36:e87-e95.
22. Osterhaus A.D., Rimmelzwaan G.F., Martina B.E., Bestebroer T.M., Fouchier R.A. Influenza B virus in seals. Science 2000, 288(5468):1051-1053.
23. Peltola V., Ziegler T., Ruuskanen O. Influenza A and B virus infections in children. Clin. Infect. Dis. 2003, 36(3):299-305.
24. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am. J. Epidemiol. 2004, 160(5):492-502.
25. Simonsen L., Fukuda K., Schonberger L.B., Cox N.J. The impact of influenza epidemics on hospitalizations. J. Infect. Dis. 2000, 181(3):831-837.
26. Skowronski D.M., De Serres G., Dickinson J., Petric M., Mak A., Fonseca K., Kwindt T.L., Chan T., Bastien N., Charest H., Li Y. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J. Infect. Dis. 2009, 199(2):168-179.
27. Smith A.B., Mock V., Melear R., Colarusso P., Willis D.E. Rapid detection of influenza A and B viruses in clinical specimens by Light Cycler real time RT-PCR. J. Clin. Virol. 2003, 28(1):51-58.
28. Sweet C., Smith H. Pathogenicity of influenza virus. Microbiol. Rev. 1980, 44(2):303-330.
29. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 2000, 74(1-2):109-116.
30. Webster R.G., Askonas B.A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 1980, 10(5):396-401.
31. Influenza activity in the world, 19 March 2010, Global alert and response 2010, World Health Organization, (http://www.who.int/csr/disease/influenza/update/en/index.html).